XORTX Therapeutics Inc. (XRTX)
USD 1.12
(-4.27%)
USD 1.12
(-4.27%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -6.58 Million | -8.81 Million | -4.75 Million | -728.4 Thousand | -249.58 Thousand | -1.55 Million |
| Net Income | -2.15 Million | -6.98 Million | -1.29 Million | -1.28 Million | -629.57 Thousand | -3.77 Million |
| Depreciation & Amortization | 139.69 Thousand | 55.45 Thousand | 14.02 Thousand | 20.43 Thousand | 19.9 Thousand | 19.31 Thousand |
| Deferred income taxes | - | -3.8 Million | -2.84 Million | -29.72 Thousand | 34.06 Thousand | -46.92 Thousand |
| Stock-based compensation | 120.98 Thousand | 487.94 Thousand | 396.42 Thousand | 230.12 Thousand | 26.31 Thousand | 275.09 Thousand |
| Change in working capital | -1.03 Million | 1.44 Million | -1.07 Million | 362.21 Thousand | 298.07 Thousand | -674.01 Thousand |
| Other non-cash items | -6425.41 | 3703.92 | 58.82 Thousand | -90.16 Thousand | 1638.00 | 2.64 Million |
| Investing Cash Flow | -46.36 Thousand | -44.22 Thousand | -31.22 Thousand | -14.35 Thousand | -7037.00 | -154.8 Thousand |
| Investments in PPE | -46.36 Thousand | -44.22 Thousand | -31.22 Thousand | -14.35 Thousand | -7037.00 | -41.07 Thousand |
| Acquisitions | - | - | - | - | - | -280.95 Thousand |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -55.72 | -35.21 | -40.22 | -14.35 | -7.04 | 167.22 Thousand |
| Financing Cash Flow | -361.04 Thousand | 4.73 Million | 19.18 Million | 855.4 Thousand | 55.21 Thousand | 1.9 Million |
| Debt repayment | -66.08 Thousand | -40.61 Thousand | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | 5.05 Million | 17.88 Million | 900 Thousand | - | 1.95 Million |
| Other Financing Activities | -295.25 Thousand | -272.26 Thousand | 1.3 Million | -44.59 Thousand | 55.21 Thousand | -49.12 Thousand |
| Accounts receivables | 21.04 Thousand | -43.61 Thousand | -29.16 Thousand | -42.99 Thousand | 14.78 Thousand | -20.06 Thousand |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | 189.01 | 1.49 Million | -1.05 Million | 405.21 Thousand | 283.28 Thousand | -653.95 Thousand |
| Cash at beginning of period | 10.43 Million | 13.88 Million | 134.32 Thousand | 58.61 Thousand | 260.01 Thousand | 61.93 Thousand |
| Cash at end of period | 3.44 Million | 10.4 Million | 14.78 Million | 171.27 Thousand | 58.61 Thousand | 260.01 Thousand |
| Capital Expenditure | -46.36 Thousand | -44.22 Thousand | -31.22 Thousand | -14.35 Thousand | -7037.00 | -41.07 Thousand |
| Effect of forex changes on cash | 4041.00 | 642.23 Thousand | 255.47 Thousand | - | - | - |
| Net cash flow / Change in cash | -6.98 Million | -3.48 Million | 14.65 Million | 112.65 Thousand | -201.4 Thousand | 198.08 Thousand |
| Free Cash Flow | -6.62 Million | -8.86 Million | -4.78 Million | -742.75 Thousand | -256.61 Thousand | -1.59 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 170.03 Thousand | -3 Million | -2.15 Million | 2.77 Million | -1.33 Million | -1.69 Million |
| Depreciation & Amortization | 33.04 Thousand | 31.98 Thousand | 139.69 Thousand | 25.03 Thousand | 16.46 Thousand | 32.02 Thousand |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | 44.03 Thousand | 53.13 Thousand | 120.98 Thousand | 28.81 Thousand | 21.85 Thousand | 30.76 Thousand |
| Change in working capital | 651.99 Thousand | -325.4 Thousand | -1.03 Million | -421.06 Thousand | 222.16 Thousand | -95.51 Thousand |
| Other non-cash items | -1.53 Million | 2.03 Million | -6425.41 | -3.66 Million | 2161.00 | -5959.00 |
| Investing Cash Flow | -9037.00 | -2611.28 | -46.36 Thousand | -10.05 Thousand | -7299.00 | -9538.00 |
| Investments in PPE | -9037.00 | -2611.28 | -46.36 Thousand | -10.05 Thousand | -7299.00 | -9538.00 |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -9084.00 | - | -55.72 | -12.98 | -9.91 | -10.47 |
| Financing Cash Flow | 3643.39 | 1.69 Million | -361.04 Thousand | -318.08 Thousand | -16.67 Thousand | -8762.00 |
| Debt repayment | -8857.00 | -15.94 Thousand | -66.08 Thousand | -17 Thousand | -16.67 Thousand | -14.97 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 12.55 Thousand | 1.71 Million | - | -300.66 Thousand | -0.20 | 6335.40 |
| Other Financing Activities | -8908.90 | -297.6 Thousand | -295.25 Thousand | -391.20 | - | 6210.00 |
| Accounts receivables | 8234.94 | 29.69 Thousand | 21.04 Thousand | 7696.50 | -37.82 Thousand | 6007.00 |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | 643.76 Thousand | -355.1 Thousand | 189.01 | -428.76 Thousand | 259.99 Thousand | -101.51 Thousand |
| Cash at beginning of period | 3.83 Million | 3.43 Million | 10.43 Million | 5.04 Million | 6.16 Million | 7.9 Million |
| Cash at end of period | 3.07 Million | 3.83 Million | 3.44 Million | 3.43 Million | 5.06 Million | 6.16 Million |
| Capital Expenditure | -9037.00 | -2611.28 | -46.36 Thousand | -10.05 Thousand | -7299.00 | -9538.00 |
| Effect of forex changes on cash | -2490.00 | -9317.00 | 4041.00 | -1453.00 | -246.00 | 4580.00 |
| Net cash flow / Change in cash | -753.46 Thousand | 401.46 Thousand | -6.98 Million | -1.61 Million | -1.09 Million | -1.74 Million |
| Free Cash Flow | -749.72 Thousand | -1.3 Million | -6.62 Million | -1.34 Million | -1.07 Million | -1.74 Million |
CTW
QBIEY
KGF
FLUOROCHEM
VINNY
TUGU